计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| L129227-1g |
1g |
现货 ![]() |
| |
| L129227-5g |
5g |
现货 ![]() |
| |
| L129227-10g |
10g |
期货 ![]() |
| |
| L129227-25g |
25g |
现货 ![]() |
| |
| L129227-100g |
100g |
现货 ![]() |
| |
| L129227-500g |
500g |
现货 ![]() |
|
| 别名 | 洛沙坦钾 | 2-丁基-4-氯-1-[[2'-(1H-四唑-5-基)-1,1'-联苯-4-基]甲基]咪唑-5-甲醇钾 | 2-丁基-4-氯-1-{[2'-(1H-四唑-5-基)(1,1'-联苯)-4-基]甲基}-1H-咪唑-5-甲醇 单钾盐 |
|---|---|
| 英文别名 | DTXSID70196363 | Losartan potassium (USAN:USP) | LOSARTAN POTASSIUM [EP MONOGRAPH] | Monopotassium Salt, Losartan | Presartan-50 | LOSARTAN POTASSIUM COMPONENT OF HYZAAR | UNII-3ST302B24A | LOSARTAN MONOPOTASSIUM SALT [MI] | LOSARTAN POTASSIUM (USP MONOGR |
| 规格或纯度 | ≥99% |
| 英文名称 | Losartan Potassium (DuP 753) |
| 生化机理 | 洛沙坦钾是血管紧张素 II 受体亚型 AT1 的特异性拮抗剂。拮抗 AT1 受体和干扰 AT1 与血管紧张素 II 之间的联系可扩张血管和降低高血压。这种拮抗作用还具有其他下游效应,包括血栓素 A2 受体的相关拮抗作用、抑制血小板聚集和诱导过氧化物酶体增殖体活性受体γ(PPARγ)的活性。阻断血管紧张素 II 的经典作用。具有降压作用,并能下调 TFG-β 的调节。体内活性 . |
| 运输条件 | 常规运输 |
| 作用类型 | 拮抗剂 |
| 作用机制 | 1 型血管紧张素 II 受体拮抗剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist. Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs introduced for clinical trials to treat hypertension. A specific antagonist of the AT1 receptor with significant downstream effects. Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist. Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs introduced for clinical trials to treat hypertension. A specific antagonist of the AT1 receptor with significant downstream effects. |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504766705 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol |
| INCHI | 1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1 |
| InChi Key | OXCMYAYHXIHQOA-UHFFFAOYSA-N |
| Smiles | CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+] |
| Isomeric SMILES | CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+] |
| PubChem CID | 11751549 |
| 分子量 | 461 |
| Beilstein号 | 5845770 |
| Reaxy-Rn | 5900704 |
| 溶解性 | Soluble in water (>500 mg/ml), PBS (pH 7.2) (≥10 mg/ml), ethanol (≥20 mg/ml), DMSO (100 mM), and DMF (≥20 mg/ml). |
|---|---|
| 敏感性 | 对湿度敏感 |
| 熔点 | 183.5 - 184.5 °C |
| 分子量 | 461.000 g/mol |
| XLogP3 | |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 6 |
| 可旋转键计数Rotatable Bond Count | 8 |
| 精确质量Exact Mass | 460.118 Da |
| 单同位素质量Monoisotopic Mass | 460.118 Da |
| 拓扑极表面积Topological Polar Surface Area | 77.700 Ų |
| 重原子数Heavy Atom Count | 31 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 526.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 2 |
| 象形图 | GHS05, GHS07, GHS08 |
|---|---|
| 信号词 | 危险 |
| 危险声明 |
H302: 吞食有害 H317: 可能引起皮肤过敏反应 H318: 造成严重的眼睛损伤 H319: 引起严重眼睛刺激 H360: 可能损害生育力或未出生的孩子 H361: 怀疑破坏生育力或未出生的孩子 H362: 可能对母乳喂养的孩子造成伤害 H373: 通过长时间或反复暴露对器官造成损害 |
| 预防措施声明 |
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P263: 避免在怀孕期间/哺乳期间接触。 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P272: 被污染的工作服不允许离开工作场所 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P330: 漱口 P302+P352: 如皮肤沾染:用水充分清洗。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P333+P313: 如发生皮肤刺激或皮疹:求医/就诊。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P203: 使用前,获取、阅读并遵守所有安全说明。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P305+P354+P338: 如果进入眼睛:立即用水冲洗几分钟。取下隐形眼镜(如果有的话),并且操作简单。继续冲洗。 P318: 如果暴露或担心,请就医。 P317: 寻求紧急医疗救助。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 |
| RTECS | NI6755100 |
| Merck Index | 5583 |
| 1. Hu B et al.. (2018) Angiotensin II facilitates GABAergic neurotransmission at postsynaptic sites in rat amygdala neurons.. Neuropharmacology, 133 (334-344). [PMID:29447844] |
| 2. Oliveira PA et al.. (2017) Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia.. Sci Rep, 7 (1857). [PMID:28500295] |
| 3. Ageeva LV et al.. (2018) Data supporting that adipose-derived mesenchymal stem/stromal cells express angiotensin II receptors in situ and in vitro.. Data Brief, 16 (327-333). [PMID:29234689] |
| 4. Sysoeva VY et al.. (2017) Local angiotensin II promotes adipogenic differentiation of human adipose tissue mesenchymal stem cells through type 2 angiotensin receptor.. Stem Cell Res, 25 (115-122). [PMID:29127873] |
| 5. Qinglin Wang, Hao Yuan, Xinyue Pan, Yiling Yang, Xiaosong Ma, Yahui Guo. (2024) Synthesis of silver nanoclusters using a double-stranded DNA template and its application for captopril detection. JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 126 (105825). [10.1016/j.jfca.2023.105825] |
| 6. Shasha Liu, Ruohan Cheng, Hui He, Kunming Ding, Rongmi Zhang, Yuanyuan Chai, Qinwei Yu, Xin Huang, Luyong Zhang, Zhenzhou Jiang. (2023) 8-methoxypsoralen protects against acetaminophen-induced liver injury by antagonising Cyp2e1 in mice. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 741 (109617). [PMID:37121295] [10.1016/j.abb.2023.109617] |
| 7. Chang Li, Benzhi Ju, Shufen Zhang. (2023) Fully bio-based hydroxy ester vitrimer synthesized by crosslinking epoxidized soybean oil with doubly esterified starch. CARBOHYDRATE POLYMERS, 302 (120442). [PMID:36604037] [10.1016/j.carbpol.2022.120442] |
| 8. Sun Zhiping, He Lingli, Yang Qingqing, Zhang Haizhi, Xu Weiren, Qin Xinguang, Liu Gang, Hu Zhongze, Zhang Luyong, Liu Changxiao. (2022) Study on the Effect of Three CYP2C9 Variants on Drug–Drug Interaction Related to Six Drugs In Vitro by LC–MS/MS Method. CHROMATOGRAPHIA, 85 (3): (221-231). [10.1007/s10337-021-04126-8] |
| 9. Yuanyuan Chai, Yunxia Xu, Ziyin Xia, Xin Huang, Luyong Zhang, Zhenzhou Jiang. (2021) Study on the effects of Zhuanggu Guanjie Pill, a modern Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats. JOURNAL OF ETHNOPHARMACOLOGY, 281 (114521). [PMID:34390794] [10.1016/j.jep.2021.114521] |
| 10. Lin Yue, Meihong Zheng, Min Wang, Imran Mahmood Khan, Bin Wang, Xiaoyuan Ma, Chifang Peng, Zhouping Wang, Wenshui Xia. (2021) A general strategy to synthesis chitosan oligosaccharide-O-Terpenol derivatives with antibacterial properties. CARBOHYDRATE RESEARCH, 503 (108315). [PMID:33865180] [10.1016/j.carres.2021.108315] |